Ligand efficiency: a useful metric for lead selection

被引：1519

作者：

Hopkins, AL ^{[1
]}

Groom, CR ^{[1
]}

Alex, A ^{[1
]}

机构：

[1] Pfizer Ltd, Global Res & Dev, Mol Informat Struct & Design, Sandwich CT13 9NJ, Kent, England

来源：

DRUG DISCOVERY TODAY | 2004年 / 9卷 / 10期

关键词：

D O I：

10.1016/S1359-6446(04)03069-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：430 / 431

页数：2

共 12 条

[1] FUNCTIONAL-GROUP CONTRIBUTIONS TO DRUG RECEPTOR INTERACTIONS [J].

ANDREWS, PR ;

CRAIK, DJ ;

MARTIN, JL .

JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (12) :1648-1657

[2]

BLAKE JF, 2003, BIOTECHNIQUES, V34, pS16

[3] Molecular complexity and its impact on the probability of finding leads for drug discovery [J].

Hann, MM ;

Leach, AR ;

Harper, G .

JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (03) :856-864

[4] The maximal affinity of ligands [J].

Kuntz, ID ;

Chen, K ;

Sharp, KA ;

Kollman, PA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :9997-10002

[5] How many leads from HTS? [J].

Lahana, R .

DRUG DISCOVERY TODAY, 1999, 4 (10) :447-448

[6] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].

Lipinski, CA ;

Lombardo, F ;

Dominy, BW ;

Feeney, PJ .

ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25

[7] Drug-like properties and the causes of poor solubility and poor permeability [J].

Lipinski, CA .

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (01) :235-249

[8] Is there a difference between leads and drugs? A historical perspective [J].

Oprea, TI ;

Davis, AM ;

Teague, SJ ;

Leeson, PD .

JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (05) :1308-1315

[9]

Sneader W., 1996, DRUG PROTOTYPES THEI

[10]

Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO

← 1 2 →